Open Access

S-glutathionylation modification of proteins and the association with cellular death (Review)

  • Authors:
    • Xiongxing Sun
    • Le Xie
    • Shiliang Wang
    • Shanshan Zeng
    • Lingying Wu
    • Xukun Tang
    • Jiajian Zhu
    • Shigao Lin
    • Tenghui Hu
    • Lin Jia
    • Xia Li
    • Songqing Zhang
    • Jun Deng
    • Dahua Wu
  • View Affiliations

  • Published online on: August 22, 2025     https://doi.org/10.3892/mi.2025.263
  • Article Number: 64
  • Copyright : © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

S-glutathionylation (SSG), a redox-sensitive post-translational modification mediated by glutathione, regulates protein structure and function through reversible disulfide bond formation at cysteine residues. Glutaredoxins (GRXs), pivotal antioxidant enzymes, catalyze SSG dynamics to maintain thiol homeostasis. Recent advances in redox proteomics have revealed that SSG dysregulation is intricately linked to neurodegenerative, cardiovascular, pulmonary and malignant diseases. Notably, GRX isoforms (GRX1 and GRX2) play compartment-specific roles in disease pathogenesis: GRX1 modulates hepatic lipid metabolism and pulmonary fibrosis, while GRX2 sustains mitochondrial redox balance and Fe-S cluster assembly. Notably, SSG functions as a ‘double-edged sword’ in programmed cell death (PCD). While moderate SSG protects against irreversible cysteine oxidation, persistent SSG accumulation due to GRX dysfunction triggers apoptosis, necroptosis and ferroptosis by disrupting redox-sensitive targets, such as caspases, BAX and glutathione peroxidase 4. The present review summarizes, for the first time, at least to the best of our knowledge, the association of SSG with distinct PCD subtypes, and highlights therapeutic strategies targeting GRX activity or site-specific SSG modulation (e.g., pyruvate kinase M2 Cys423/424). Emerging approaches, including GRX mimetics and thiol-targeted drugs, hold promise for precision medicine in redox-related pathologies.
View Figures
View References

Related Articles

Journal Cover

November-December 2025
Volume 5 Issue 6

Print ISSN: 2754-3242
Online ISSN:2754-1304

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun X, Xie L, Wang S, Zeng S, Wu L, Tang X, Zhu J, Lin S, Hu T, Jia L, Jia L, et al: S-glutathionylation modification of proteins and the association with cellular death (Review). Med Int 5: 64, 2025.
APA
Sun, X., Xie, L., Wang, S., Zeng, S., Wu, L., Tang, X. ... Wu, D. (2025). S-glutathionylation modification of proteins and the association with cellular death (Review). Medicine International, 5, 64. https://doi.org/10.3892/mi.2025.263
MLA
Sun, X., Xie, L., Wang, S., Zeng, S., Wu, L., Tang, X., Zhu, J., Lin, S., Hu, T., Jia, L., Li, X., Zhang, S., Deng, J., Wu, D."S-glutathionylation modification of proteins and the association with cellular death (Review)". Medicine International 5.6 (2025): 64.
Chicago
Sun, X., Xie, L., Wang, S., Zeng, S., Wu, L., Tang, X., Zhu, J., Lin, S., Hu, T., Jia, L., Li, X., Zhang, S., Deng, J., Wu, D."S-glutathionylation modification of proteins and the association with cellular death (Review)". Medicine International 5, no. 6 (2025): 64. https://doi.org/10.3892/mi.2025.263